Development of a nanoprecipitation method for the entrapment of a very water soluble drug into Eudragit RL nanoparticles

Abstract

Rivastigmine hydrogen tartrate (RHT), one of the potential cholinesterase inhibitors, has received great attention as a new drug candidate for the treatment of Alzheimer's disease. However, the bioavailability of RHT from the conventional pharmaceutical forms is low because of the presence of the blood brain barrier. The main aim of the present study was to prepare positively charged Eudragit RL 100 nanoparticles as a model scaffold for providing a sustained release profile for RHT. The formulations were evaluated in terms of particle size, zeta potential, surface morphology, X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), and differential scanning calorimetry (DSC). Drug entrapment efficiency and in vitro release properties of lyophilized nanoparticles were also examined. The resulting formulations were found to be in the size range of 118 nm to 154 nm and zeta potential was positive (+22.5 to 30 mV). Nanoparticles showed the entrapment efficiency from 38.40 ± 8.94 to 62.00 ± 2.78%. An increase in the mean particle size and the entrapment efficiency was observed with an increase in the amount of polymer. The FTIR, XRD, and DSC results ruled out any chemical interaction between the drug and Eudragit RL100 polymer. RHT nanoparticles containing low ratio of polymer to drug (4:1) presented a faster drug release and on the contrary, nanoparticles containing high ratio of polymer to drug (10:1) were able to give a more sustained release of the drug. The study revealed that RHT nanoparticles were capable of releasing the drug in a prolonged period of time and increasing the drug bioavailability.

Encapsulation of Hibiscus sabdariffa Extract into Zein Nanoparticles

“…Keeping on increasing the mass of zein, the trapping ability of the nanoparticles did not change, but the ratio TP/m z OUT decreased due to the higher value of the denominator. This trend was also observed by other authors and it is common in nanoprecipitation processes [48,49]. Fig.…”

An integrated vitamin E-coated polymer hybrid nanoplatform: A lucrative option for an enhanced in vitro macrophage retention for an anti-hepatitis B therapeutic prospect

“…In nanoprecipitation, nanoparticles are formed by interfacial phenomena due to the convection effects caused by interfacial turbulence. A physicochemical instability is produced by solvent transport and local regions of supersaturation are formed [68]. It might be assumed that turbulence, applied for a specified time, would enhance the evaporation of the organic solvent preventing drug leakage.…”

Cyclodextrin Based Nanoparticles for Drug Delivery and Theranostics

“…1 The drug is dissolved, dispersed, encapsulated, entrapped or attached to NP matrix. 2,3 Depending on the method of preparation, nanospheres (the drug is uniformly dispersed in a matrix) or nanocapsules (the drug is confined in a cavity) are obtained which possess different properties and release characteristics suitable for best drug delivery or drug encapsulation. 4 Due to the small size of NPs they can penetrate tissues and small capillaries offering advantages including long circulation time, improvements in the target to non-target concentration ratio, increased residence at target site and improved cellular uptake.…”